Shorted
Painchek logo
PCK
Health Care Equipment & Services

Painchek

Short interest
0.00%
0.00 pp 30d
as of 21 May 2026
Reported shorts
1.5K
Shares on issue
209.007M

Painchek (PCK) company profile

Profile, insiders and operations

Company

AI-generated research profile of Painchek

healthcare
pain management
medical devices
aged care
AI

Painchek is focused on developing and commercializing mobile medical applications for pain assessment, particularly for individuals with communication difficulties. Their core product, PainChek®, is a regulatory-cleared medical device that uses AI to assess pain through facial analysis and other indicators. The company aims to improve pain management and medication treatment for vulnerable populations in aged care and other settings.

Director trades

20 trades recorded

DateDirectorTypeSharesPriceValue
2026-09-30Unknown Director
buy
---
2026-09-28Adam Davey
exercise options
48,426--
2026-08-05Unknown Director
buy
---
2026-08-03Adam Davey
buy
48,426--
2026-06-26Unknown Director
buy
---
2026-06-19John Murray
exercise options
1,573,851--
2025-12-30Unknown Director
buy
---
2025-12-23Unknown Director
buy
---
2025-12-22Philip Daffas
buy
176,471$0.340$60,000
2025-12-19John Murray
sell
240,000--
2025-10-27Unknown Director
buy
---
2025-10-22Philip Daffas
other
7,164,895--
2025-10-01Unknown Director
buy
---
2025-09-26John Murray
exercise options
1,133,144--
2025-09-19Unknown Director
buy
---
2025-09-12Adam Davey
exercise options
1,133,144--
2024-12-23Unknown Director
buy
---
2024-12-19John Murray
exercise options
4,800,000$0.013$60,000
2024-10-04Unknown Director
buy
---
2024-09-30John Murray
exercise options
1,431,981--

PCK intelligence dossier

Public-source evidence for this company, with industry drill-up links.

  • Tax paid and taxable income records
  • Government contracts and public money
  • Emissions and trade exposure
  • Political donations and lobbying links
Sign in to unlock the dossierFree account · no card required